By Dean Seal

Shares of Rapid Micro Biosystems rose after the company said its Growth Direct platform has been selected by Samsung Biologics for the automation of microbial quality control processes.

The stock was up 9% at 98 cents in recent trading. Shares were trading at around $1.38 a year ago.

The life-sciences technology company said before the bell on Thursday that Samsung Biologics picked the platform to help increase efficiency and deliver more robust data integrity as well as scalable quality control operations.

No further details about the arrangement were given.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

January 04, 2024 10:06 ET (15:06 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.
Rapid Micro Biosystems (NASDAQ:RPID)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Rapid Micro Biosystems
Rapid Micro Biosystems (NASDAQ:RPID)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Rapid Micro Biosystems